Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-04 Hunt Anthony Chief Executive Officer Shares withheld for taxes −1,111 $193.99 $216K 212,097
2024-03-04 Gebski Christine See Remarks Shares withheld for taxes −131 $193.99 $25K 28,139
2024-03-04 Bylund James Chief Operating Officer Shares withheld for taxes −197 $193.99 $38K 22,263
2024-03-04 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −135 $193.99 $26K 26,892
2024-03-04 Gebski Christine See Remarks Shares withheld for taxes −461 $192.71 $89K 28,270
2024-03-01 Bylund James Chief Operating Officer Grant or award +50 22,460
2024-03-01 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −453 $191.79 $87K 27,027
2024-03-01 Hunt Anthony Chief Executive Officer Shares withheld for taxes −3,322 $191.79 $637K 213,208
2024-03-01 Gebski Christine See Remarks Shares withheld for taxes −447 $191.79 $86K 28,731
2024-03-01 Bylund James Chief Operating Officer Shares withheld for taxes −820 $191.79 $157K 22,410
2024-02-29 KURIYEL RALF Senior VP, R&D Grant or award +404 27,480
2024-02-29 Hunt Anthony Chief Executive Officer Grant or award +2,504 216,530
2024-02-29 Gebski Christine See Remarks Grant or award +391 29,178
2024-02-29 Bylund James Chief Operating Officer Grant or award +404 23,230
2024-02-27 Bylund James Chief Operating Officer Grant or award +8,691 22,826
2024-02-27 Bylund James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +8,632 8,632
2024-02-27 Hunt Anthony Chief Executive Officer Grant or award +19,719 214,026
2024-02-27 Hunt Anthony Chief Executive Officer Grant or award · Stock Option (Right to Buy) +19,585 19,585
2024-02-27 KURIYEL RALF Senior VP, R&D Grant or award +3,520 27,076
2024-02-27 KURIYEL RALF Senior VP, R&D Grant or award · Stock Option (Right to Buy) +3,497 3,497

Page 13 of 23 · 455 trades